NeoImmuneTech, Inc. (KOSDAQ:950220)
South Korea
· Delayed Price · Currency is KRW
640.00
+24.00 (3.90%)
At close: Dec 5, 2025
NeoImmuneTech Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 63,275 | 111,226 | 200,207 | 394,816 | 1,018,357 | - | |
| Market Cap Growth | -53.96% | -44.44% | -49.29% | -61.23% | - | - | |
| Enterprise Value | 3,351 | 74,945 | 122,886 | 259,580 | 856,774 | - | |
| Last Close Price | 640.00 | 934.40 | 1681.92 | 3318.17 | 8596.50 | - | |
| PS Ratio | 671.08 | 652.79 | - | - | - | - | |
| PB Ratio | 0.96 | 2.67 | 2.68 | 3.30 | 6.29 | - | |
| P/TBV Ratio | 1.11 | 3.16 | 2.92 | 3.49 | 6.55 | - | |
| EV/Sales Ratio | 35.54 | 439.86 | - | - | - | - | |
| Debt / Equity Ratio | 0.18 | 0.26 | 0.05 | 0.04 | 0.04 | 0.03 | |
| Asset Turnover | 0.00 | 0.00 | - | - | - | - | |
| Quick Ratio | 3.49 | 1.68 | 5.36 | 7.14 | 7.57 | 7.91 | |
| Current Ratio | 3.63 | 1.89 | 5.61 | 7.20 | 8.17 | 8.96 | |
| Return on Equity (ROE) | -53.36% | -70.17% | -54.90% | -42.88% | -42.62% | -30.44% | |
| Return on Assets (ROA) | -21.70% | -32.84% | -30.30% | -22.25% | -22.95% | -18.02% | |
| Return on Capital (ROIC) | -27.48% | -39.04% | -34.34% | -24.88% | -25.45% | -18.99% | |
| Return on Capital Employed (ROCE) | -41.10% | -91.80% | -71.90% | -47.10% | -31.20% | -36.10% | |
| Earnings Yield | -46.87% | -36.76% | -26.67% | -15.30% | -5.15% | - | |
| FCF Yield | -49.40% | -39.35% | -25.25% | -11.37% | -3.59% | - | |
| Buyback Yield / Dilution | -223.96% | -0.02% | -0.08% | -3.68% | -15.27% | -1.50% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.